核磁気共鳴分光法の市場規模、シェア、動向分析レポート：タイプ別、製品別、最終用途別、地域別、セグメント別予測、2024年～2030年

核磁気共鳴分光法市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、核磁気共鳴分光法の世界市場規模は2030年までに10億8,000万米ドルに達する見込みです。

市場は2024～2030年にかけてCAGR 5.1％で拡大すると予測されています。メタボロミクス別の診断のニーズの高まりと様々なセグメントでの利用の増加が相まって、市場の急成長が見込まれています。ブルカーは、マルチオミクス、組織SpatialOMx、プロテオミクス、機能的構造生物学、生体分子凝縮、バイオファーマと応用向けに核磁気共鳴（NMR）分光ソリューションを提供しています。

NMR分光法市場は2021年に漸増し、予測期間中も同様の動向を示すと予測されます。学術・大学研究センターからの装置需要が収益に大きく貢献しています。例えば、2021年6月、全米科学財団は、ジョージア大学、UConn医療部、UW-Madison's National Magnetic Resonance Facility at Madison間のNetwork for Advanced NMR（NAN）を開発するために4,000万米ドルの投資を発表しました。

ジェネリック医薬品の急速な需要拡大、医療における技術改善、核磁気共鳴分光法業界における政府の取り組みや助成金など、その他の決定要因も市場の成長に寄与しています。米国では、NMR分光装置を含む装置の購入を支援するために、政府出資の-S10 Instrumentation Programsが設立されています。2023年6月を期限とする3つの活発な資金援助プログラムがあります。これらのプログラムは2万5,000米ドルから200万0,000米ドルの範囲です。

COVID-19の流行は、同製品の需要にプラスの影響を与えると予想されます。しかし、供給不足と原材料価格の高騰は、参入企業の収益性に影響を与えました。超電導体に使用される銅、鉄、金属などの主要原材料の価格は過去10年間で上昇しています。

がん診断薬に対する需要の増加は、今後数年間の市場成長を大きく牽引すると予想されます。パーキンソン病、がん、感染症、精神疾患の診断は、NMR分光法を用いて研究されています。例えば、2022年1月には、オックスフォード大学で、NMRメタボロミクスによって、さまざまながんを特定できる新しい血液試験を開発する研究が行われました。

一方で、これは参入企業が限られたニッチ市場です。さらに、NMR分光法は、400MHzで数十万米ドル、高磁場マグネットでは数100万米ドルもするため、かさばり、高価であると考えられています。さらに、定期的に極低温流体で満たされた高磁場磁石が必要で、電子機器やプローブの定期的なメンテナンスが必要なため、コストが増大します。

核磁気共鳴分光法市場レポートハイライト

• 製品別では、大学や研究センターによる高磁場NMR分光法の需要増加により、装置セグメントがNMR分光法業界で圧倒的なシェアを占めています。
• 製品の範囲が着実に広がっていることが市場に大きな影響を与えています。例えば、固体NMR分光法（SSNMR）は、薬剤の特性解析のための分析ツールと考えられており、それゆえ市場成長を促進しています。
• タイプ別では、高磁場NMR分光法セグメントが2023年の市場を独占しました。
• 最終用途別では、学術セグメントが2023年に大きなシェアを占めました。多くの大学が、製薬や化学産業における化学物質の同定を強化するためにNMR分析を採用しています。
• 北米は、多数の大学が存在し、研究インフラを強化するために政府による資金援助が増加していることから、2023年の世界市場で大きなシェアを占めました。
• アジア太平洋は、原材料の入手可能性の上昇と製薬・バイオテクノロジー産業における生物医療研究の増加により、将来的に大きく成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブ概要

第3章 核磁気共鳴分光法市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場ドライバー分析
  • 市場抑制要因分析
• 核磁気共鳴分光法市場分析ツール
  • 業界分析-ポーターのファイブフォース分析
  • PESTEL分析
  • NMR分光法市場における主要な利害関係者

第4章 核磁気共鳴分光法市場：製品推定・動向分析

• 世界の核磁気共鳴分光法市場：製品、ダッシュボード
• 世界の核磁気共鳴分光法市場：製品変動分析
• 世界の核磁気共鳴分光法市場：製品別、収益別
• 機器
• 消耗品

第5章 核磁気共鳴分光法市場：タイプ、推定・動向分析

• 世界の核磁気共鳴分光法市場：タイプダッシュボード
• 世界の核磁気共鳴分光法市場：タイプ変動分析
• 世界の核磁気共鳴分光法市場：タイプ別、収益別
• 低磁場NMR分光法
• 高磁場NMR分光法

第6章 核磁気共鳴分光法市場：最終用途、推定・動向分析

• 世界の核磁気共鳴分光法市場：最終用途ダッシュボード
• 世界の核磁気共鳴分光法市場：最終用途変動分析
• 世界の核磁気共鳴分光法市場：最終用途別、収益別
• アカデミック
• 製薬・バイオテクノロジー企業
• 農業と食品
• 化学産業
• その他

第7章 核磁気共鳴分光法市場：タイプ、製品、用途、最終用途別の地域推定・動向分析

• 地域ダッシュボード
• 市場規模と予測動向分析、2018～2030年
• 北米
• 欧州
• アジア太平洋
• ラテンアメリカ
• 中東・アフリカ

第8章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業/競合の分類
• ベンダー情勢
  • 主要企業の市場シェア分析、2023年
  • JEOL Ltd.
  • Thermo Fisher Scientific Inc.
  • Bruker
  • Magritek
  • Oxford Instruments
  • Nanalysis Corp.
  • Anasazi Instruments, Inc.
  • QOneTec
  • Advanced Magnetic Resonance Limited

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 4 Global Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 5 Global Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 6 Global Nuclear Magnetic Resonance Spectroscopy, by Region, 2018 - 2030 (USD Million)
• Table 7 North America Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
• Table 8 North America Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 9 North America Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 10 North America Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 11 U.S. Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 12 U.S. Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 13 U.S. Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 14 Canada Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 15 Canada Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 16 Canada Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 17 Europe Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
• Table 18 Europe Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 19 Europe Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 20 Europe Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 21 Germany Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 22 Germany Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 23 Germany Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 24 UK Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 25 UK Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 26 UK Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 27 France Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 28 France Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 29 France Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 30 Italy Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 31 Italy Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 32 Italy Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 33 Spain Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 34 Spain Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 35 Spain Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 36 Denmark Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 37 Denmark Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 38 Denmark Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 39 Sweden Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 40 Sweden Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 41 Sweden Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 42 Norway Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 43 Norway Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 44 Norway Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 45 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
• Table 46 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 49 China Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 50 China Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 51 China Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 52 Japan Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 53 Japan Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 54 Japan Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 55 India Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 56 India Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 57 India Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 58 South Korea Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 59 South Korea Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 60 South Korea Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 61 Australia Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 62 Australia Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 63 Australia Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 64 Singapore Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 65 Singapore Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 66 Singapore Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 67 Thailand Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 68 Thailand Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 69 Thailand Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 70 Latin America Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
• Table 71 Latin America Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 72 Latin America Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 73 Latin America Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 74 Brazil Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 75 Brazil Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 76 Brazil Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 77 Mexico Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 78 Mexico Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 79 Mexico Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 80 Argentina Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 81 Argentina Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 82 Argentina Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 83 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by Country, 2018 - 2030 (USD Million)
• Table 84 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 85 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 86 Middle East & Africa Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 87 South Africa Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 88 South Africa Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 89 South Africa Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 90 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 91 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 92 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 93 UAE Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 94 UAE Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 95 UAE Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)
• Table 96 Kuwait Nuclear Magnetic Resonance Spectroscopy, by Product, 2018 - 2030 (USD Million)
• Table 97 Kuwait Nuclear Magnetic Resonance Spectroscopy, by Type, 2018 - 2030 (USD Million)
• Table 98 Kuwait Nuclear Magnetic Resonance Spectroscopy, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Primary Research Pattern
• Fig. 4 Market Research Approaches
• Fig. 5 Value Chain-Based Sizing & Forecasting
• Fig. 6 Market Formulation & Validation
• Fig. 7 Nuclear Magnetic Resonance Spectroscopy Market Segmentation
• Fig. 8 Market Snapshot, 2023
• Fig. 9 Market Trends & Outlook
• Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
• Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 14 Porter's Five Forces Analysis
• Fig. 15 Global Nuclear Magnetic Resonance Spectroscopy Market: Product Movement Analysis
• Fig. 16 Global Nuclear Magnetic Resonance Spectroscopy Market, for Instruments, 2018 - 2030 (USD Million)
• Fig. 17 Global Nuclear Magnetic Resonance Spectroscopy Market, for Consumables, 2018 - 2030 (USD Million)
• Fig. 18 Global Nuclear Magnetic Resonance Spectroscopy Market: Type Movement Analysis
• Fig. 19 Global Nuclear Magnetic Resonance Spectroscopy Market, for Low-field NMR Spectroscopy, 2018 - 2030 (USD Million)
• Fig. 20 Global Nuclear Magnetic Resonance Spectroscopy Market, for High-field NMR Spectroscopy, 2018 - 2030 (USD Million)
• Fig. 21 Global Nuclear Magnetic Resonance Spectroscopy Market: End-use Movement Analysis
• Fig. 22 Global Nuclear Magnetic Resonance Spectroscopy Market, for Academic, 2018 - 2030 (USD Million)
• Fig. 23 Global Nuclear Magnetic Resonance Spectroscopy Market, for Pharmaceutical and Biotech Companies, 2018 - 2030 (USD Million)
• Fig. 24 Global Nuclear Magnetic Resonance Spectroscopy Market, for Agriculture and Food, 2018 - 2030 (USD Million)
• Fig. 25 Global Nuclear Magnetic Resonance Spectroscopy Market, for Chemical Industry, 2018 - 2030 (USD Million)
• Fig. 26 Global Nuclear Magnetic Resonance Spectroscopy Market, for Others, 2018 - 2030 (USD Million)
• Fig. 27 Regional Marketplace: Key Takeaways
• Fig. 28 Regional Outlook, 2023 & 2030
• Fig. 29 Global Nuclear Magnetic Resonance Spectroscopy Market: Region Movement Analysis
• Fig. 30 North America Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 31 U.S. Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 32 Canada Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 33 Europe Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 34 Germany Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 35 UK Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 36 France Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 37 Italy Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 38 Spain Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 39 Denmark Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 40 Sweden Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 41 Norway Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 42 Asia Pacific Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 43 Japan Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 44 China Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 45 India Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 46 Australia Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 47 South Korea Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 48 Singapore Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 49 Thailand Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 50 Latin America Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 51 Brazil Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 52 Mexico Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 53 Argentina Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 54 Middle East and Africa Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 55 South Africa Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 56 Saudi Arabia Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 57 UAE Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)
• Fig. 58 Kuwait Nuclear Magnetic Resonance Spectroscopy Market, 2018 - 2030 (USD Million)

Nuclear Magnetic Resonance Spectroscopy Market Growth & Trends:

The global nuclear magnetic resonance spectroscopy market size is expected to reach USD 1.08 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 5.1% from 2024 to 2030. The rising need for metabolomics-based diagnosis, coupled with increasing usage in various fields, is anticipated to surge the growth of the market. Bruker offers nuclear magnetic resonance (NMR) spectroscopy solutions for multi-omics, tissue SpatialOMx, proteomics, functional structural biology, biomolecular condensates, and biopharma and applied.

The market for NMR spectroscopy witnessed incremental growth in 2021 and is anticipated to showcase a similar trend in the forecast period. The instrument demand from academic and university research centers is a significant contributor to the revenue. For instance, in June 2021, National Science Foundation announced an investment of USD 40 million to develop the Network for Advanced NMR (NAN) between the University of Georgia, UConn School of Medicine, and UW-Madison's National Magnetic Resonance Facility at Madison.

Other determinants such as the rapidly expanding demand for generic medicine, technical improvements in healthcare, as well as government initiatives and grants in the nuclear magnetic resonance spectroscopy industry are also contributing to the market's growth. In the U.S., government-funded - S10 Instrumentation Programs have been formed to support the purchase of instruments, including NMR spectroscopy. There are three active funding programs with June 2023 as the deadline. These programs range from USD 25,000 to USD 2,000,000.

The COVID-19 pandemic is anticipated to positively impact the demand for the product. However, supply shortages and accelerated prices of raw materials impacted the profitability of the players. The prices of key raw materials such as copper, steel, and metallic, used for superconductors, have risen over the last decade.

The increasing demand for cancer diagnostics is expected to majorly drive market growth in the coming years. Diagnosis for Parkinson's disease, cancer, infectious diseases, and psychiatric disorders, has been investigated with the use of NMR spectroscopy. For instance, in January 2022, a study was conducted at the University of Oxford to develop a new blood test, through NMR metabolomics, that can identify a range of cancers.

On the other hand, this is a niche market with limited players. Additionally, NMR spectroscopy is considered to be bulky and expensive, as its cost ranges from around a few hundred thousand dollars for 400 MHz, to millions for higher field magnets. Additionally, the requirement of high-field magnets, filled with cryogenic fluids regularly, and routine maintenance of electronics and probes increases the cost.

Nuclear Magnetic Resonance Spectroscopy Market Report Highlights:

• By product, the instruments segment held the dominant share of the NMR spectroscopy industry, owing to the increasing demand by universities and research centers for high-field NMR spectroscopy
• The steadily increasing scope of the product has a significant impact on the market. For instance, solid-state NMR spectroscopy (SSNMR) is considered an analytical tool for drug characterization, hence propelling the market growth
• By type, the high-field NMR spectroscopy segment dominated the market in 2023, since it offers better sensitivity to the researchers
• By end-use, the academic segment held a larger share in 2023; numerous universities employ NMR analysis to enhance chemical identification in pharmaceutical and chemical industries
• North America held a substantial share in the global market in 2023 due to the presence of a large number of universities and increasing funding support by the government to enhance research infrastructure
• The Asia Pacific region is projected to grow considerably in the future, owing to the rising availability of raw materials and increasing biomedical research in the pharma and biotech industry

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Type
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product and type outlook
  • 2.2.2. End-use outlook
  • 2.2.3. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Nuclear Magnetic Resonance Spectroscopy Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Development Of Generic Drugs / API
    • 3.2.1.2. Acceleration In Biomedical Research
    • 3.2.1.3. Increasing Metabolomics-Based Diagnosis
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Expensive Equipment And Maintenance At Low Sensitivity
    • 3.2.2.2. The Presence Of Interfering Substances Disrupts The Research
• 3.3. Nuclear Magnetic Resonance Spectroscopy Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
  • 3.3.3. Key Stakeholders in the NMR Spectroscopy Market

Chapter 4. Nuclear Magnetic Resonance Spectroscopy Market: Product Estimates & Trend Analysis

• 4.1. Global Nuclear Magnetic Resonance Spectroscopy Market: Product Dashboard
• 4.2. Global Nuclear Magnetic Resonance Spectroscopy Market: Product Movement Analysis
• 4.3. Global Nuclear Magnetic Resonance Spectroscopy Market by Product, Revenue
• 4.4. Instruments
  • 4.4.1. Instruments market estimates and forecasts 2018 - 2030 (USD Million)
• 4.5. Consumables
  • 4.5.1. Consumables market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 5. Nuclear Magnetic Resonance Spectroscopy Market: Type Estimates & Trend Analysis

• 5.1. Global Nuclear Magnetic Resonance Spectroscopy Market: Type Dashboard
• 5.2. Global Nuclear Magnetic Resonance Spectroscopy Market: Type Movement Analysis
• 5.3. Global Nuclear Magnetic Resonance Spectroscopy Market by Type, Revenue
• 5.4. Low-field NMR Spectroscopy
  • 5.4.1. Low-field NMR spectroscopy market estimates and forecasts 2018 - 2030 (USD Million)
• 5.5. High-field NMR spectroscopy
  • 5.5.1. High-field NMR Spectroscopy market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 6. Nuclear Magnetic Resonance Spectroscopy Market: End Use Estimates & Trend Analysis

• 6.1. Global Nuclear Magnetic Resonance Spectroscopy Market: End Use Dashboard
• 6.2. Global Nuclear Magnetic Resonance Spectroscopy Market: End Use Movement Analysis
• 6.3. Global Nuclear Magnetic Resonance Spectroscopy Market by End Use, Revenue
• 6.4. Academic
  • 6.4.1. Academic market estimates and forecasts 2018 - 2030 (USD Million)
• 6.5. Pharmaceutical and Biotech Companies
  • 6.5.1. Pharmaceutical and biotech companies market estimates and forecasts 2018 - 2030 (USD Million)
• 6.6. Agriculture and Food
  • 6.6.1. Agriculture and food market estimates and forecasts 2018 - 2030 (USD Million)
• 6.7. Chemical Industry
  • 6.7.1. Chemical industry market estimates and forecasts 2018 - 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Others market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 7. Nuclear Magnetic Resonance Spectroscopy Market: Regional Estimates & Trend Analysis by Type, Tube Material, Application, and End-use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 - 2030
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4.6. Denmark
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Denmark market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.4.8. Norway
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Norway market estimates and forecasts 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.4. South Korea
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. South Korea market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.5. Australia
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. Australia market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.6. Singapore
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Singapore market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Regulatory framework/ reimbursement structure
    • 7.5.7.3. Competitive scenario
    • 7.5.7.4. Thailand market estimates and forecasts 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.2. Mexico
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Mexico market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Argentina market estimates and forecasts 2018 - 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 - 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Key company market share analysis, 2023
  • 8.3.4. JEOL Ltd.
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Product benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Thermo Fisher Scientific Inc.
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Product benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Bruker
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Product benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. Magritek
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Product benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Oxford Instruments
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Product benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Nanalysis Corp.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Product benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Anasazi Instruments, Inc.
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Product benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. QOneTec
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Product benchmarking
    • 8.3.11.4. Strategic initiatives
  • 8.3.12. Advanced Magnetic Resonance Limited
    • 8.3.12.1. Company overview
    • 8.3.12.2. Financial performance
    • 8.3.12.3. Product benchmarking
    • 8.3.12.4. Strategic initiatives